Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Renovaro Biosciences ( (RENB) ) has provided an update.
Renovaro Inc. received a notice from Nasdaq on July 7, 2025, for non-compliance with the requirement to hold an annual meeting of shareholders within twelve months of the fiscal year-end. Nasdaq accepted the company’s plan to regain compliance, granting an extension until October 31, 2025, to hold the meeting.
More about Renovaro Biosciences
Average Trading Volume: 3,669,929
Technical Sentiment Signal: Sell
Current Market Cap: $57.13M
See more insights into RENB stock on TipRanks’ Stock Analysis page.